A-share CXO sector benefits from the good performance of innovative drug development.

Wind information data shows that out of the 29 listed companies in the A-share CXO sector, 20 companies achieved year-on-year revenue growth in the first three quarters. Reporters have learned from the industry that internationalization is driving the performance growth of innovative pharmaceutical companies, which are located upstream in the innovative pharmaceutical industry chain and are known as the industry's "picks and shovels" CXO sector. The sector has also seen an increase in demand, leading to overall performance growth. Overall, the current innovative pharmaceutical industry is benefiting from policy promotion and demand explosion, both of which are jointly stimulating the demand for new drug research and development and further transmitting to the upstream CXO sector of the industry chain.